Cena s DPH / bez DPH
Hlavní stránka>BS EN ISO 5840-2:2021 Cardiovascular implants. Cardiac valve prostheses Surgically implanted heart valve substitutes
sklademVydáno: 2021-02-08
BS EN ISO 5840-2:2021 Cardiovascular implants. Cardiac valve prostheses Surgically implanted heart valve substitutes

BS EN ISO 5840-2:2021

Cardiovascular implants. Cardiac valve prostheses Surgically implanted heart valve substitutes

Formát
Dostupnost
Cena a měna
Anglicky Zabezpečené PDF
K okamžitému stažení
8700 Kč
Čtěte normu po dobu 1 hodiny. Více informací v kategorii E-READING
Čtení normy
na 1 hodinu
870.00 Kč
Čtěte normu po dobu 24 hodin. Více informací v kategorii E-READING
Čtení normy
na 24 hodin
2610.00 Kč
Anglicky Tisk
Skladem
8700 Kč
Označení normy:BS EN ISO 5840-2:2021
Počet stran:60
Vydáno:2021-02-08
ISBN:978 0 539 02791 4
Status:Standard
Popis

BS EN ISO 5840-2:2021


This standard BS EN ISO 5840-2:2021 Cardiovascular implants. Cardiac valve prostheses is classified in these ICS categories:
  • 11.040.40 Implants for surgery, prosthetics and orthotics

This document is applicable to heart valve substitutes intended for implantation in human hearts, generally requiring cardiopulmonary bypass and generally with direct visualization. See Annex E for examples of surgical heart valve substitutes and their components.

This document is applicable to both newly developed and modified surgical heart valve substitutes and to the accessory devices, packaging, and labelling required for their implantation and for determining the appropriate size of the surgical heart valve substitute to be implanted.

This document establishes an approach for verifying/validating the design and manufacture of a surgical heart valve substitute through risk management. The selection of appropriate qualification tests and methods are derived from the risk assessment. The tests can include those to assess the physical, chemical, biological, and mechanical properties of surgical heart valve substitutes and of their materials and components. The tests can also include those for pre-clinical in vivo evaluation and clinical evaluation of the finished surgical heart valve substitute.

This document defines operational conditions and performance requirements for surgical heart valve substitutes where adequate scientific and/or clinical evidence exists for their justification.

For some heart valve substitutes (e.g. sutureless), the requirements of both this document and ISO 5840-3:2021 can be relevant and are considered as applicable to the specific device design and are based on the results of the risk analysis.